IDiyas

For the Inventor, By the Inventor

Pennington, NJ, United States of America

Timur Gungor

USPTO Granted Patents = 16


Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 93(Granted Patents)


Location History:

  • Hopewell, NJ (US) (2006)
  • Pennington, NJ (US) (2006 - 2012)

Company Filing History:

goldMedal16 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents

Years Active: 2006-2012

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8329718 - N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions (2012-12-11),
2. 8053450 - [object Object] (2011-11-08),
3. 7728008 - [object Object] (2010-06-01),
4. 7674828 - [object Object] (2010-03-09),
5. 7550499 - [object Object] (2009-06-23),
6. 7470712 - [object Object] (2008-12-30),
7. 7456188 - C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators (2008-11-25),
8. 7388021 - [object Object] (2008-06-17),
9. 7381730 - 3-arylquinazoline derivatives as selective estrogen receptor beta modulators (2008-06-03),
10. 7312218 - Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors (2007-12-25),
11. 7205322 - Thiazolidine compounds as calcium sensing receptor modulators (2007-04-17),
12. 7205318 - Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors (2007-04-17),
13. 7169795 - Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors (2007-01-30),
14. 7122557 - Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors (2006-10-17),
15. 7105537 - 2-substituted cyclic amines as calcium sensing receptor modulators (2006-09-12),

Title: Innovations of Timur Gungor

Introduction

Timur Gungor is a prominent inventor based in Pennington, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on developing novel compounds that can be used in medical treatments.

Latest Patents

One of his latest patents is titled "N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions." This invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles, which are selective inhibitors of the human P2Y receptor. These compounds can be utilized as medicaments for treating thrombotic conditions. Another recent patent involves "novel amino-benzazoles and analogues thereof," which are also selective inhibitors of the human P2Y receptor. This invention includes various pharmaceutical compositions and methods for treating diseases responsive to modulation of P2Y receptor activity.

Career Highlights

Timur Gungor is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and develop new pharmaceutical solutions. His extensive experience and expertise in the field have made him a valuable asset to the company.

Collaborations

Some of his notable coworkers include Jennifer X Qiao and Tammy C Wang, with whom he collaborates on various projects within the pharmaceutical domain.

Conclusion

Timur Gungor's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical treatments. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…